Literature DB >> 25943049

[Adenoviral keratoconjunctivitis].

U Pleyer1, F Birnbaum.   

Abstract

Keratoconjunctivitis caused by adenoviruses (epidemic keratoconjunctivitis, EKC, ICD-10 B30.0+) is common, can be severe and may cause significant morbidity. In the early stages of adenoviral infections it is often difficult to differentiate the clinical presentation from other causes of a red eye. Because of its highly contagious nature that can rapidly lead to epidemic outbreaks, prompt viral identification and prevention of further spread are major challenges. Even today the diagnosis is still mainly clinical, with laboratory tests only rarely contributing. New diagnostic tests, such as the Rapid Pathogen Detector (RPS, Sarasota FL) AdenoPlus detection kit, that are practical, rapid and inexpensive to use in the general practice may obviate these problems. Because of its highly resistant properties to desiccation and highly developed escape mechanisms which protect the virus from the host's immune response, long-term problems often remain. Remnants of viral proteins often persist on the corneal surface of Bowman's layer for a long time and may lead to the formation of subepithelial infiltrates. No treatment other than symptomatic eye drops is available. The major sequelae are subepithelial infiltrates, which are difficult to treat. Cyclosporin A eye drops are a good option with a low risk profile. The use of topical steroids can possibly be disadvantageous but can be discussed at all stages of the disease. As nosocomial spread of adenoviruses is relatively common, preventive measures remain a major responsibility for ophthalmologists.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25943049     DOI: 10.1007/s00347-015-0006-x

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  42 in total

Review 1.  Immune evasion by adenoviruses.

Authors:  J A Mahr; L R Gooding
Journal:  Immunol Rev       Date:  1999-04       Impact factor: 12.988

2.  Novel gene therapeutic strategies for the induction of tolerance in cornea transplantation.

Authors:  Thomas Ritter; Uwe Pleyer
Journal:  Expert Rev Clin Immunol       Date:  2009-11       Impact factor: 4.473

Review 3.  Epidemic keratoconjunctivitis: the current situation and recommendations for prevention and treatment.

Authors:  Birthe Meyer-Rüsenberg; Ulrike Loderstädt; Gisbert Richard; Paul-Michael Kaulfers; Caroline Gesser
Journal:  Dtsch Arztebl Int       Date:  2011-07-08       Impact factor: 5.594

Review 4.  Adenoviruses types, cell receptors and local innate cytokines in adenovirus infection.

Authors:  Rong-Fu Chen; Chun-Yi Lee
Journal:  Int Rev Immunol       Date:  2013-10-15       Impact factor: 5.311

5.  Rapid diagnosis of adenoviral keratoconjunctivitis by a fully automated molecular assay.

Authors:  Christoph Koidl; Michael Bozic; Georg Mossböck; Gerhard Mühlbauer; Jörg Berg; Markus Stöcher; Jasmin Dehnhardt; Egon Marth; Harald H Kessler
Journal:  Ophthalmology       Date:  2005-09       Impact factor: 12.079

6.  Real-time qualitative PCR for 57 human adenovirus types from multiple specimen sources.

Authors:  Seanne P Buckwalter; Rose Teo; Mark J Espy; Lynne M Sloan; Thomas F Smith; Bobbi S Pritt
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

7.  [The effects of topical steroids in epidemic kerato-conjunctivitis (author's transl)].

Authors:  S Trauzettel-Klosinski; R Sundmacher; R Wigand
Journal:  Klin Monbl Augenheilkd       Date:  1980-06       Impact factor: 0.700

Review 8.  Adenoviral keratoconjunctivitis: an update.

Authors:  J J González-López; R Morcillo-Laiz; F J Muñoz-Negrete
Journal:  Arch Soc Esp Oftalmol       Date:  2012-09-25

Review 9.  Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients.

Authors:  Tony Walls; A G Shankar; Delane Shingadia
Journal:  Lancet Infect Dis       Date:  2003-02       Impact factor: 25.071

10.  The effects of corticosteroids of adenoviral replication.

Authors:  E G Romanowski; L A Roba; L Wiley; T Araullo-Cruz; Y J Gordon
Journal:  Arch Ophthalmol       Date:  1996-05
View more
  1 in total

1.  Epidemic keratoconjunctivitis: efficacy of outbreak management.

Authors:  Cristina Martin; Ursula Löw; Adrien Quintin; Gesine Schießl; Barbara Gärtner; Albert Heim; Berthold Seitz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-08-18       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.